Inhaled antibiotic-loaded polymeric nanoparticles for the management of lower respiratory tract infections-Reference-Cited by-同舟云学术

Inhaled antibiotic-loaded polymeric nanoparticles for the management of lower respiratory tract infections

Published:2021 Issue:14 Volume:3 Page:4005-4018
ISSN:2516-0230
Container-title:Nanoscale Advances
language:en
Short-container-title:Nanoscale Adv.

Author:

Rahman Sabuj Mohammad Zaidur¹²³⁴⁵^ORCID,Islam Nazrul¹²³⁴⁵^ORCID

Affiliation:

1. Pharmacy Discipline

2. School of Clinical Sciences

3. Queensland University of Technology (QUT)

4. Brisbane

5. Australia

Abstract

A schematic diagram of pulmonary drug delivery from the DPI formulation, which consists of drug encapsulated in polymer nanoparticles. Nanoparticles are aerosolized using a DPI device and the patient's inspiratory force for lung deposition.

Funder

Queensland University of Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

General Engineering,General Materials Science,General Chemistry,Atomic and Molecular Physics, and Optics,Bioengineering

Link

http://pubs.rsc.org/en/content/articlepdf/2021/NA/D1NA00205H

Reference199 articles.

1. A. Biggers and J.Fletcher , Lower respiratory tract infections: what to know , 2019

2. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016

3. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

4. Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparative investigation of release kinetics of paclitaxel from natural protein and macromolecular nanocarriers in nanoscale drug delivery systems;JCIS Open;2024-10

2. Lipid polymer hybrid nanoparticles against lung cancer and their application as inhalable formulation;Nanomedicine;2024-08-15

3. SAFETY OF THE USE OF AEROSOL FORM OF CEPHALOSPORIN ANTIBIOTICS FOR LUNGS (EXPERIMENTAL STUDY);Chemistry for Sustainable Development;2024-08-12

4. Interactions between prokaryotic polysaccharides and colloidal magnetic nanoparticles for bacteria removal: A strategy for circumventing antibiotic resistance;International Journal of Biological Macromolecules;2024-08

5. Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseases;Journal of Nanobiotechnology;2024-06-18